|
|
Am. J. Biomed. Sci. 2013, 5(2), 80-108; doi: 10.5099/aj130200080 |
The Issues of Antioxidant Therapy |
Boris V. Nemzer1*, Alexander Y. Yashin2, |
1
Department of Research &
Development, VDF FutureCeuticals, Inc., |
2
Scientific |
*Corresponding
Author |
Boris
Nemzer |
Director
of Research and Development |
FutureCeuticals, Inc. |
Momence, IL 60954 USA |
Email: bnemzer@vandrunen.com |
Abstract Interest in antioxidants and antioxidant therapy has been
growing during the last decade. Antioxidants are generally considered to have
the capability to protect people from harmful effects of reactive oxygen and
nitrogen species (RONSs), including free radicals (FR), when these are present
in excessive amounts. RONS and free radicals perform a variety of useful
biological functions in the body. Their excess is controlled by a natural
antioxidant protection system in humans. This protection is provided at three
levels: by simple molecules (such as cysteine,
glutathione (GSH), uric acid, ubiquinol, etc.),
medium-molecular weight, and high molecular weight compounds (enzymes, etc.). Under
certain adverse conditions, this system does not manage to provide adequate
protection and the RONSs and free radicals begin to damage vital DNA, proteins,
and lipids. In such a case, antioxidant therapy, which includes antioxidant
supplements and foods containing natural antioxidants, has been suggested to be
of possible benefit. However, there are many unresolved issues related to the
effective use of an antioxidant therapy: 1. A person should know the content of antioxidants in everyday
food products and its relation to the storage time and processing methods used.
2. How many antioxidants should a person consume? It is
known that at high concentrations some antioxidants become pro-oxidants. 3. Are the antioxidants consumed by a person bioavailable and, if so, to what extent; for some food
products, bioavailability has already been determined but most foods have not
been examined. 4. Many antioxidants are digested by intestinal microflora before they reach the systemic blood circulation. 5. Even those antioxidants that do reach the blood are often rapidly
metabolized; the role of their metabolites is unclear; there is some evidence
that certain metabolites are also antioxidants. 6. How long do antioxidants and their metabolites stay in
the body; how are they distributed in different organs; and when are they
excreted? In order to answer these questions, the pharmacokinetics of
antioxidants should be studied. 7. The presence of oxidative stress, i.e., excess amounts
of RONSs and free radicals, can be detected by various oxidative stress markers
but, in order to see the whole picture, the actual concentrations of RONSs and
free radicals should also be monitored. In
vivo determination of RONSs and free radicals is almost never conducted. All these questions must
be addressed in order to provide appropriate antioxidant therapy. This could be
extremely important because it could be used to detect and even prevent diseases
at early stages of development. Keywords:
Antioxidants, antioxidant therapy, oxidative stress, free radicals, polyphenols, diet. Download the full article (PDF)
|
Publisher | Missions and Scope | Editorial Board | Instructions for Authors |
© American Journal of Biomedical Sciences 2007-2021. All Rights Reserved. |